The pharmacologic basis of antihypertensive therapy: The role of vasodilator drugs.
D000317:Adrenergic alpha-Antagonists / Q000009:adverse effects / Q000627:therapeutic use; D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D001158:Arteries / Q000187:drug effects; D003981:Diazoxide / Q000627:therapeutic use; D004232:Diuretics / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D005730:Ganglionic Blockers / Q000009:adverse effects; D006146:Guanidines / Q000627:therapeutic use; D006321:Heart / Q000187:drug effects; D006801:Humans; D006830:Hydralazine / Q000627:therapeutic use; D006973:Hypertension / Q000188:drug therapy*; D007668:Kidney / Q000187:drug effects; D008914:Minoxidil / Q000627:therapeutic use; D009573:Nitrites / Q000627:therapeutic use; D011433:Propranolol / Q000627:therapeutic use; D014665:Vasodilator Agents / Q000378:metabolism / Q000627:therapeutic use*; D014680:Veins / Q000187:drug effects
D000317:Adrenergic alpha-Antagonists; D000319:Adrenergic beta-Antagonists; D004232:Diuretics; D005730:Ganglionic Blockers; D006146:Guanidines; D009573:Nitrites; D014665:Vasodilator Agents; D006830:Hydralazine; D008914:Minoxidil; D011433:Propranolol; D003981:Diazoxide